ITRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Background: Proteome studies for multiple renal diseases is bare. Methodology & results: Using isobaric tags for relative and absolute quantitation labeling, many differentially expressed proteins (DEPs) were identified in acute kidney injury (AKI), AKI + chronic kidney disease (CKD), diabetic CKD and nondiabetic CKD with or without IgA nephropathy (IgAN). Comparative analysis indicated that 34, 35, 17, 91 and 14 unique DEPs were found in AKI, AKI + CKD, CKD, diabetic CKD and nondiabetic CKD. Compared with nondiabetic CKD with IgAN, 47 unique DEPs were found in that without IgAN. Serum amyloid A1 (SAA1) and hepatocyte growth factor activator were unregulated in AKI and nondiabetic CKD without IgAN, respectively. Regenerating islet-derived protein 3-α (Reg3A) upregulation is associated with AKI and AKI + CKD patients. Conclusion: This research contributes to urinary biomarker discovery from multiple renal diseases.

Cite

CITATION STYLE

APA

Jin, J., Gong, J., Zhao, L., Li, Y., Wang, Y., & He, Q. (2020). ITRAQ-based comparative proteomics analysis reveals specific urinary biomarkers for various kidney diseases. Biomarkers in Medicine, 14(10), 839–854. https://doi.org/10.2217/bmm-2019-0556

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free